Clinical trial
STIMULATE Study: Anemia Correction and Health-related Quality of Life (HRQoL)…
NCT00364845 · Amgen, Industry · Terminated
Key facts
| NCT number | NCT00364845 |
|---|---|
| Title | STIMULATE Study: Anemia Correction and Health-related Quality of Life (HRQoL) Outcomes in Elderly Chronic Kidney Disease (CKD) Patients |
| Official title | A Randomised Single-Blind Study to Improve Health-related Quality of Life as Measured by the Short-Form 36 (SF-36) Vitality Score by Correcting Anemia With Aranesp (Darbepoetin Alfa) in the Elderly. |
| Lead sponsor | Amgen, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia, Chronic Kidney Disease |
| Intervention type | Drug |
| Interventions | Darbepoetin alfa, Placebo |
| Enrollment | 51 |
| Start date | Sep 1, 2006 |
| Primary completion | Dec 1, 2008 |
| Completion | Feb 1, 2009 |
| First posted | Aug 16, 2006 |
| Last update posted | May 21, 2014 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: